HCV - Insulin Resistance / Diabetes

Insulin Resistance Linked to Poor Hepatitis C Treatment Response in HIV/HCV Coinfected Patients
10-04-2010

Statin and Diabetes Drug Show Activity against Hepatitis B Virus in
Laboratory Studies
12-04-09

Sustained Response to Interferon-based Therapy Reduces Risk of Diabetes in Hepatitis C Patients
4/21/09

Insulin-sensitizing Agent Pioglitazone (Actos) Did Not Improve Response to Re-treatment with Pegylated Interferon plus Ribavirin
8/29/2008

Obesity and Diabetes Are Linked to Increased Risk of Liver Cancer
7/18/08

Insulin Resistance and Diabetes Increase the Risk of Liver Fibrosis and Hepatocellular Carcinoma in People with Chronic Hepatitis C
7/04/08

Sustained Response to Interferon-based Therapy Reduces the Likelihood of Type 2 Diabetes
6/24/08

Insulin Resistance and Diabetes Increase the Risk of Liver Fibrosis and Hepatocellular Carcinoma in People with Chronic Hepatitis C
6/24/08

Sustained Response to Interferon-based Therapy Reduces the Likelihood of Type 2 Diabetes
6/24/08

Cirrhosis
Fibrosis
Hepatocellular Carcinoma
Liver Transplantation
Liver Biopsy
Steatosis
Anemia
Children / Infants / Women
Drug Abuse
Experimental Treatments
FAQs About Hepatitis C
Genotypes
Insulin Resistance / Diabetes
Sustained Viral Response (SVR)
Tests for HCV
Vaccines for HCV